(VIANEWS) – Paysign (PAYS), SilverSun Technologies (SSNT), Opera Limited (OPRA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Paysign (PAYS)
17.3% sales growth and 8.67% return on equity
PaySign, Inc. provides prepaid card products and processing services under the PaySign brand for corporate, consumer, and government applications. It offers various services, such as transaction processing, cardholder enrollment, value loading, cardholder account management, reporting, and customer service through PaySign, a card processing platform. The company also develops prepaid card programs for corporate incentive and rewards, including consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments, and pharmaceutical payment assistance; and payroll or general purpose reloadable cards, as well as gift or incentive cards. In addition, it offers Per Diem, Corporate Expense, and Business Travel Cards that allows businesses, and non–profits and government agencies the ability to control employee spending while reducing administration costs by eliminating the need for traditional expense reports. Further, the company provides payment claims processing and other administrative services; pharmacy-based voucher and copay, and medical claims and debit-based affordability programs; PaySign Premier, a demand deposit account debit card; and payment solution for source plasma collection centers, as well as customer service center and PaySign Communications Suite services. Its principal target markets for processing services comprise prepaid card issuers, retail and private-label issuers, small third-party processors, and small and mid-size financial institutions in the United States and Mexico. The company was formerly known as 3PEA International, Inc. and changed its name to PaySign, Inc. in April 2019. PaySign, Inc. was incorporated in 1995 and is headquartered in Henderson, Nevada.
Earnings Per Share
As for profitability, Paysign has a trailing twelve months EPS of $0.02.
PE Ratio
Paysign has a trailing twelve months price to earnings ratio of 93.5. Meaning, the purchaser of the share is investing $93.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.67%.
Sales Growth
Paysign’s sales growth is 17.7% for the present quarter and 17.3% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 50% and positive 100% for the next.
Volume
Today’s last reported volume for Paysign is 41075 which is 68.73% below its average volume of 131371.
2. SilverSun Technologies (SSNT)
13.2% sales growth and 4.78% return on equity
SilverSun Technologies, Inc. operates as a business application, technology, and consulting company in the United States. The company provides solutions for accounting and business management, financial reporting, managed services, enterprise resource planning, human capital management, warehouse management systems, customer relationship management, and business intelligence. It also offers value-added services that focuses on consulting and professional services, specialized programming, training, and technical support. In addition, the company provides managed, cybersecurity, business continuity, disaster recovery, data back-up, network maintenance and service upgrades, and application hosting services. It serves small and medium-sized businesses primarily in the manufacturing, distribution, and service industries. The company was formerly known as Trey Resources, Inc. and changed its name to SilverSun Technologies, Inc. in June 2011. SilverSun Technologies, Inc. was founded in 1988 and is headquartered in East Hanover, New Jersey.
Earnings Per Share
As for profitability, SilverSun Technologies has a trailing twelve months EPS of $0.1.
PE Ratio
SilverSun Technologies has a trailing twelve months price to earnings ratio of 34. Meaning, the purchaser of the share is investing $34 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.78%.
Volume
Today’s last reported volume for SilverSun Technologies is 3976 which is 62.8% below its average volume of 10690.
Moving Average
SilverSun Technologies’s value is under its 50-day moving average of $3.52 and higher than its 200-day moving average of $3.28.
Revenue Growth
Year-on-year quarterly revenue growth grew by 24.6%, now sitting on 49.71M for the twelve trailing months.
Sales Growth
SilverSun Technologies’s sales growth is 22.5% for the present quarter and 13.2% for the next.
3. Opera Limited (OPRA)
11.1% sales growth and 6.9% return on equity
Opera Limited, together with its subsidiaries, provides mobile and PC web browsers. It operates in two segments, Browser and News, and Other. The company offers mobile browser products, such as Opera Mini, Opera for Android and iOS, Opera GX Mobile, and Opera Touch; PC browsers, including Opera for Computers and Opera GX; Apex Football; Opera VPN Pro; and Opera News, an AI-powered personalized news discovery and aggregation service. It also provides Opera Crypto Browser for PCs and mobile; browser-based cashback rewards; owns GameMaker Studio, a 2D gaming development platform; and GXC, a gaming portal. In addition, the company operates Opera Ads, an online advertising platform. It operates in Nigeria, Ireland, France, Germany, Spain, England, South Africa, Kenya, and internationally. The company was founded in 1995 and is headquartered in Oslo, Norway. Opera Limited is a subsidiary of Kunlun Tech Limited.
Earnings Per Share
As for profitability, Opera Limited has a trailing twelve months EPS of $0.6.
PE Ratio
Opera Limited has a trailing twelve months price to earnings ratio of 17.93. Meaning, the purchaser of the share is investing $17.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.9%.
Sales Growth
Opera Limited’s sales growth is 21.6% for the current quarter and 11.1% for the next.
4. Synergetics USA (SURG)
10.8% sales growth and 130.07% return on equity
SurgePays, Inc., through its subsidiaries, provides telecommunication services in the United States. It offers discounted and free wireless services for federal programs, such as SNAP (EBT) and Medicaid; subsidized wireless service to qualifying low income customers; repaid wireless plans with talk, text, and 4G LTE data; and client acquisition and retention services for attorneys and law firms by operating digital marketing campaigns. The company also provides financial technology tech and wireless top-up platform; and SurgePays Blockchain software, an e-commerce platform, which offer wholesale goods and services direct to convenience stores, bodegas, minimarts, tiendas, and other corner stores. In addition, it provides sales support, customer, IT infrastructure design, graphic media, database programming, software development, revenue assurance, lead generation, call center support, and other services. The company was formerly known as Surge Holdings, Inc. and changed its name to SurgePays, Inc. in November 2020. SurgePays, Inc. is headquartered in Bartlett, Tennessee.
Earnings Per Share
As for profitability, Synergetics USA has a trailing twelve months EPS of $0.82.
PE Ratio
Synergetics USA has a trailing twelve months price to earnings ratio of 5.71. Meaning, the purchaser of the share is investing $5.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 130.07%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 28.1%, now sitting on 143.06M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Synergetics USA’s EBITDA is 15.78.
Volume
Today’s last reported volume for Synergetics USA is 65560 which is 69.06% below its average volume of 211946.
Moving Average
Synergetics USA’s worth is under its 50-day moving average of $5.04 and way under its 200-day moving average of $5.60.
5. Merit Medical Systems (MMSI)
7.5% sales growth and 7.87% return on equity
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, fluid management, electrophysiology and cardiac rhythm management, and hemodynamic monitoring to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, swab and collection systems, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, advanced over-the-wire and direct visualization delivery systems, and dilation balloons; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Earnings Per Share
As for profitability, Merit Medical Systems has a trailing twelve months EPS of $1.58.
PE Ratio
Merit Medical Systems has a trailing twelve months price to earnings ratio of 43.68. Meaning, the purchaser of the share is investing $43.68 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.87%.
Yearly Top and Bottom Value
Merit Medical Systems’s stock is valued at $69.02 at 16:22 EST, way below its 52-week high of $85.62 and way above its 52-week low of $54.66.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 1.6% and a drop 2.5% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Merit Medical Systems’s EBITDA is 3.62.
